TY - JOUR
T1 - Safety and Effectiveness of the Titanium mAXIS Stapes Prosthesis
T2 - Multicentric Short-Term Outcome
AU - Beutner, Dirk
AU - Bevis, Nicholas
AU - Loader, Benjamin
AU - Windisch, Franz
AU - Arndt, Susan
AU - Offergeld, Christian
AU - Wolfram, Wendelin
AU - Niederwanger, Lisa
AU - Zwittag, Paul Martin
AU - Rubicz, Nina
AU - Schimanski, Esther
AU - Arnoldner, Christoph
AU - Riss, Dominik
AU - Skarżyński, Piotr H
AU - Plichta, Łukasz
AU - Hornung, Joachim
AU - Taha, Lava
AU - Lenarz, Thomas
AU - Busch, Susan
AU - Magele, Astrid
AU - Sprinzl, Georg
N1 - Publisher Copyright:
© Wolters Kluwer Health, Inc. All rights reserved.
PY - 2025/2/19
Y1 - 2025/2/19
N2 - OBJECTIVE: Otosclerosis leads to ossification of the stapes footplate and is responsible for a significant number of patients having hearing loss. Stapes surgery is a treatment for otosclerosis with excellent postoperative hearing outcomes. The aim of this retrospective study was to analyze the safety and effectiveness of the titanium mAXIS prosthesis in a multicentric setting.METHODS: Ninety-four surgeries with implantation of the mAXIS stapes prosthesis took place in a multicenter study group. During follow-up at 59 (±48.1) days, pure-tone audiometry was performed. The pure-tone averages of 0.5, 1, 2, and 3 kHz (PTA-4) were determined.RESULTS: No device-related adverse events were reported. There were 88 patients who reported for follow-up, at which pure-tone audiometry was performed. The PTA-4 air-bone gap (ABG) at follow-up was 8.8 (±6.0) dB. In 64.8% of the patients, the postoperative PTA-4 ABG was within 10 dB and in 94.3% it was within 20 dB. The postoperative PTA-4 thresholds for bone conduction were stable in 95.5% of cases.CONCLUSION: The results of this multicentric study demonstrate the safety of the mAXIS titanium stapes prosthesis. The prosthesis shows promising audiological outcomes. Future studies are needed to assess long-term efficacy.
AB - OBJECTIVE: Otosclerosis leads to ossification of the stapes footplate and is responsible for a significant number of patients having hearing loss. Stapes surgery is a treatment for otosclerosis with excellent postoperative hearing outcomes. The aim of this retrospective study was to analyze the safety and effectiveness of the titanium mAXIS prosthesis in a multicentric setting.METHODS: Ninety-four surgeries with implantation of the mAXIS stapes prosthesis took place in a multicenter study group. During follow-up at 59 (±48.1) days, pure-tone audiometry was performed. The pure-tone averages of 0.5, 1, 2, and 3 kHz (PTA-4) were determined.RESULTS: No device-related adverse events were reported. There were 88 patients who reported for follow-up, at which pure-tone audiometry was performed. The PTA-4 air-bone gap (ABG) at follow-up was 8.8 (±6.0) dB. In 64.8% of the patients, the postoperative PTA-4 ABG was within 10 dB and in 94.3% it was within 20 dB. The postoperative PTA-4 thresholds for bone conduction were stable in 95.5% of cases.CONCLUSION: The results of this multicentric study demonstrate the safety of the mAXIS titanium stapes prosthesis. The prosthesis shows promising audiological outcomes. Future studies are needed to assess long-term efficacy.
UR - http://www.scopus.com/inward/record.url?scp=105001701274&partnerID=8YFLogxK
U2 - 10.1097/MAO.0000000000004462
DO - 10.1097/MAO.0000000000004462
M3 - Journal article
C2 - 40059729
SN - 1531-7129
JO - Otology and Neurotology
JF - Otology and Neurotology
ER -